Evidence map›Paper›PMID 40588666›Full record

ArticleEJNMMI reports2025

Myocardium-to-cavity ratio derived from simultaneous

Shozo Yamashita, Kenichi Nakajima, Teppei Kitano, Hiromu Kato, Tatsuya Yoneyama, Haruki Yamamoto, Kunihiko Yokoyama

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shozo YamashitaDivision of Radiology, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa, 924-8588, Japan.
Kenichi NakajimaDepartment of Nuclear Medicine, Kanazawa University, Kanazawa, Ishikawa, 920-8640, Japan. nakajima@med.kanazawa-u.ac.jp.ORCID http://orcid.org/0000-0001-7188-8746
Teppei KitanoDepartment of Cardiology, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa, 924-8588, Japan.
Hiromu KatoDivision of Radiology, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa, 924-8588, Japan.
Tatsuya YoneyamaDivision of Thyroid, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa, 924-8588, Japan.
Haruki YamamotoDivision of Radiology, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa, 924-8588, Japan.
Kunihiko YokoyamaPET Imaging Center, Public Central Hospital of Matto Ishikawa, 3-8 Kuramitsu, Hakusan, Ishikawa, 924-8588, Japan.

Funding

Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province No. 23K07203
6 · The paper itself

Abstract

backgroundThe heart-to-contralateral lung (H/CL) ratio, derived from planar imaging, is a standard quantitative metric in METHODS/

resultsWe retrospectively analyzed 121 consecutive patients with suspected cardiac amyloidosis who underwent dual-isotope

conclusionsThe M/C ratio demonstrated superior diagnostic accuracy compared to the H/CL ratio, particularly in eliminating false positive cases. Its simplicity and reproducibility make it a promising alternative for routine clinical practice, potentially replacing the H/CL ratio in dual-isotope imaging.

Indexed as

Dual-isotope tomographyMyocardium-to-cavity ratioTransthyretin-type amyloidosis

Identifiers

PMID40588666
PMCPMC12209077

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.